Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $225.91 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPTOVUE, INC. | $63.42 | 1 | $0 (2019) |
| ABBVIE INC. | $42.89 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $39.69 | 2 | $0 (2024) |
| TearLab Corp | $24.64 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $22.81 | 1 | $0 (2017) |
| Rayner Intraocular Lenses Limited | $20.71 | 1 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $11.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.83 | 2 | ABBVIE INC. ($24.12) |
| 2023 | $64.46 | 3 | Bausch & Lomb Americas Inc. ($24.98) |
| 2019 | $63.42 | 1 | OPTOVUE, INC. ($63.42) |
| 2018 | $11.75 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($11.75) |
| 2017 | $47.45 | 2 | TearLab Corp ($24.64) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Ophthalmology | ||||||
| 01/09/2024 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: EYE CARE | ||||||
| 11/29/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 11/03/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: EYE CARE | ||||||
| 05/16/2023 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $20.71 | General |
| Category: Ophthalmology | ||||||
| 12/03/2019 | OPTOVUE, INC. | OCT (Device) | Food and Beverage | Cash or cash equivalent | $63.42 | General |
| Category: Optometry | ||||||
| 01/16/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | AMVISC PLUS (Device) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2017 | TearLab Corp | TearLab Osmolarity System (Device) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: Diagnostics | ||||||
| 06/20/2017 | Valeant Pharmaceuticals North America LLC | AMVISC PLUS (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,179 | 3,785 | $1.1M | $288,805 |
| 2022 | 14 | 3,336 | 4,667 | $1.1M | $312,666 |
| 2021 | 16 | 3,775 | 4,373 | $1.5M | $397,043 |
| 2020 | 17 | 2,980 | 3,821 | $1.2M | $330,485 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 989 | 1,008 | $193,500 | $80,938 | 41.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 124 | 495 | $443,052 | $79,732 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 360 | $58,580 | $29,926 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 321 | $36,915 | $19,073 | 51.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 75 | 87 | $65,118 | $18,566 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 156 | 156 | $37,630 | $16,762 | 44.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 343 | 357 | $46,410 | $15,673 | 33.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 352 | 363 | $72,046 | $8,318 | 11.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 155 | 227 | $34,504 | $6,912 | 20.0% |
| 92134 | Imaging of retina | Office | 2023 | 217 | 236 | $46,808 | $6,527 | 13.9% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 11 | 19 | $21,432 | $3,034 | 14.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 92 | 94 | $7,050 | $1,711 | 24.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 11 | 11 | $2,450 | $842.24 | 34.4% |
| 92250 | Photography of the retina | Office | 2023 | 30 | 30 | $3,650 | $659.51 | 18.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 21 | 21 | $735.00 | $130.28 | 17.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 141 | 577 | $506,718 | $93,087 | 18.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,060 | 1,073 | $193,140 | $86,164 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 338 | 443 | $50,945 | $27,128 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 310 | $48,050 | $25,012 | 52.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 75 | 90 | $67,320 | $21,049 | 31.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 376 | 387 | $50,310 | $16,723 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 119 | 119 | $27,370 | $12,861 | 47.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 390 | 399 | $79,002 | $9,130 | 11.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 155 | 239 | $36,328 | $7,429 | 20.5% |
| 92134 | Imaging of retina | Office | 2022 | 207 | 221 | $43,758 | $6,261 | 14.3% |
About Dr. Mark Szal, MD
Dr. Mark Szal, MD is a Ophthalmology healthcare provider based in Concord, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588665475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Szal, MD has received a total of $225.91 in payments from pharmaceutical and medical device companies, with $38.83 received in 2024. These payments were reported across 9 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($225.91).
As a Medicare-enrolled provider, Szal has provided services to 13,270 Medicare beneficiaries, totaling 16,646 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Concord, NH
- Active Since 08/02/2005
- Last Updated 04/21/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1588665475
Products in Payments
- OCT (Device) $63.42
- LUMIGAN (Drug) $42.89
- AMVISC PLUS (Device) $34.56
- MIEBO (Drug) $24.98
- TearLab Osmolarity System (Device) $24.64
- Omidria (Drug) $20.71
- VYZULTA (Drug) $14.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Concord
David Weinberg, Md, MD
Ophthalmology — Payments: $57,670
Joshua Rheinbolt, Md, MD
Ophthalmology — Payments: $7,750
Dr. Karen Graham, Md, MD
Ophthalmology — Payments: $6,345
Dr. Arun Prasad, Md, MD
Ophthalmology — Payments: $6,043
Dr. Clark Tsai, M.d, M.D
Ophthalmology — Payments: $5,618
Jerome Ramos Esteban, Md, MD
Ophthalmology — Payments: $2,900